Literature DB >> 12860916

Influence of anterior mitral leaflet second-order chordae tendineae on left ventricular systolic function.

Sten Lyager Nielsen1, Tomasz A Timek, G Randall Green, Paul Dagum, George T Daughters, J Michael Hasenkam, Ann F Bolger, Neil B Ingels, D Craig Miller.   

Abstract

BACKGROUND: The contribution of anterior mitral leaflet second-order ("strut") chordae tendineae to left ventricular (LV) systolic mechanics is debated; we measured the in vivo contribution of anterior chordae tendineae (ACT) and posterior chordae tendineae (PCT) to regional and global LV contractile function. METHODS AND
RESULTS: Eight sheep had radiopaque markers implanted in the LV epicardium, partitioning the ventricle into 12 regions. Microminiature force transducers and snares were sutured to anterior leaflet "strut" chordae originating from ACT and PCT papillary muscles. Chordal tension, marker images, and hemodynamic data were acquired before and after (CUT) severing ACT and PCT. Fractional area shrinkage and slope of the regional end-diastolic area-regional stroke work relation (r-PRSW) were computed for each LV region. CUT did not affect global LV systolic function but reduced FAS in LV segments near the PCT insertion site: equatorial posterior lateral (19+/-2% versus 16+/-2%, P<0.05), apical posterior lateral (23+/-4% versus 19+/-4%, P<0.05), and posterior medial LV segments (16+/-2% versus 13+/-2%, P<0.05). r-PRSW fell near both the ACT (equatorial anterior medial [84+/-8 versus 62+/-11 mm Hg, P<0.05] and lateral [73+/-7 versus 53+/-9 mm Hg, P<0.05]) and PCT (apical posterior medial [91+/-12 versus 67+/-17 mm Hg, P<0.05] and lateral [72+/-8 versus 59+/-9 mm Hg, P<0.05]) LV insertion sites. Maximum tension in PCT was higher than in ACT (0.81+/-0.1 versus 0.52+/-0.08N, P<0.01).
CONCLUSIONS: Dividing anterior leaflet strut chordae in sheep was associated acutely with regional LV systolic dysfunction near the chordal insertion sites. Caution is necessary when embarking on procedures that cut second-order chordae to treat ischemic mitral regurgitation, since this may compromise LV systolic function in ventricles that are already impaired.

Entities:  

Mesh:

Year:  2003        PMID: 12860916     DOI: 10.1161/01.CIR.0000080504.70265.05

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  6 in total

1.  Biomimetic six-axis robots replicate human cardiac papillary muscle motion: pioneering the next generation of biomechanical heart simulator technology.

Authors:  Annabel M Imbrie-Moore; Matthew H Park; Michael J Paulsen; Mark Sellke; Rohun Kulkami; Hanjay Wang; Yuanjia Zhu; Justin M Farry; Alexandra T Bourdillon; Christine Callinan; Haley J Lucian; Camille E Hironaka; Daniela Deschamps; Y Joseph Woo
Journal:  J R Soc Interface       Date:  2020-12-02       Impact factor: 4.118

2.  Comprehensive annular and subvalvular repair of chronic ischemic mitral regurgitation improves long-term results with the least ventricular remodeling.

Authors:  Catherine Szymanski; Alain Bel; Iris Cohen; Bernard Touchot; Mark D Handschumacher; Michel Desnos; Alain Carpentier; Philippe Menasché; Albert A Hagège; Robert A Levine; Emmanuel Messas
Journal:  Circulation       Date:  2012-11-08       Impact factor: 29.690

Review 3.  Geometric description for the anatomy of the mitral valve: A review.

Authors:  Diana Oliveira; Janaki Srinivasan; Daniel Espino; Keith Buchan; Dana Dawson; Duncan Shepherd
Journal:  J Anat       Date:  2020-04-03       Impact factor: 2.921

4.  Morphological study of chordae tendinae in human cadaveric hearts.

Authors:  S A Gunnal; R N Wabale; M S Farooqui
Journal:  Heart Views       Date:  2015 Jan-Mar

5.  A comparative study of the morphology of mammalian chordae tendineae of the mitral and tricuspid valves.

Authors:  Jennifer Hutchison; Paul Rea
Journal:  Vet Rec Open       Date:  2015-11-26

Review 6.  Anatomy of Mitral Valve Complex as Revealed by Non-Invasive Imaging: Pathological, Surgical and Interventional Implications.

Authors:  Laura Anna Leo; Vera Lucia Paiocchi; Susanne Anna Schlossbauer; Elisa Gherbesi; Francesco F Faletra
Journal:  J Cardiovasc Dev Dis       Date:  2020-11-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.